BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21159900)

  • 1. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
    Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
    Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
    Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
    J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.
    Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L
    Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.
    Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L
    Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
    Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
    Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].
    Hartung-Knemeyer V; Müller S; Nagarajah J; Lahner H; Broecker-Preuss M; Bockisch A; Görges R
    Nuklearmedizin; 2012; 51(4):125-32. PubMed ID: 22526413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
    Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
    J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin precursor levels in human medullary thyroid carcinoma.
    Bihan H; Becker KL; Snider RH; Nylen E; Vittaz L; Lauret C; Modigliani E; Moretti JL; Cohen R
    Thyroid; 2003 Aug; 13(8):819-22. PubMed ID: 14558925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
    Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
    Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
    Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
    Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.